HUP0103505A2 - Benzoxazin- és benzotiazin-származékok, eljárás az előállításukra, valamint alkalmazásuk gyógyszerkészítményekben - Google Patents

Benzoxazin- és benzotiazin-származékok, eljárás az előállításukra, valamint alkalmazásuk gyógyszerkészítményekben

Info

Publication number
HUP0103505A2
HUP0103505A2 HU0103505A HUP0103505A HUP0103505A2 HU P0103505 A2 HUP0103505 A2 HU P0103505A2 HU 0103505 A HU0103505 A HU 0103505A HU P0103505 A HUP0103505 A HU P0103505A HU P0103505 A2 HUP0103505 A2 HU P0103505A2
Authority
HU
Hungary
Prior art keywords
benzoxazine
medicines
preparation
benzothiazine derivatives
benzothiazine
Prior art date
Application number
HU0103505A
Other languages
English (en)
Inventor
Gerardine Anne Burton
Margrit Hillmann
Peter Hölscher
Stefan Jaroch
Fiona Mcdougall Mcdonald
Hartmut Rehwinkel
Detlev Sülzle
Original Assignee
Schering Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag. filed Critical Schering Ag.
Publication of HUP0103505A2 publication Critical patent/HUP0103505A2/hu
Publication of HUP0103505A3 publication Critical patent/HUP0103505A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
HU0103505A 1998-09-18 1999-09-16 Benzoxazine and benzothiazine derivatives, process for their preparation and their use in medicines HUP0103505A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19844291A DE19844291A1 (de) 1998-09-18 1998-09-18 Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln
PCT/EP1999/007089 WO2000017173A1 (de) 1998-09-18 1999-09-16 Benzoxazin- und benzothiazin-derivate und deren verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
HUP0103505A2 true HUP0103505A2 (hu) 2002-02-28
HUP0103505A3 HUP0103505A3 (en) 2003-05-28

Family

ID=7882416

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103505A HUP0103505A3 (en) 1998-09-18 1999-09-16 Benzoxazine and benzothiazine derivatives, process for their preparation and their use in medicines

Country Status (22)

Country Link
US (1) US6841550B1 (hu)
EP (1) EP1114037B1 (hu)
JP (1) JP2002526481A (hu)
KR (1) KR20010075199A (hu)
CN (1) CN1144794C (hu)
AR (1) AR020474A1 (hu)
AT (1) ATE266647T1 (hu)
AU (1) AU751381B2 (hu)
BR (1) BR9913856A (hu)
CA (1) CA2341170A1 (hu)
CZ (1) CZ2001988A3 (hu)
DE (2) DE19844291A1 (hu)
DK (1) DK1114037T3 (hu)
ES (1) ES2221442T3 (hu)
HU (1) HUP0103505A3 (hu)
NO (1) NO20011339L (hu)
NZ (1) NZ510562A (hu)
PE (1) PE20001035A1 (hu)
PL (1) PL346699A1 (hu)
PT (1) PT1114037E (hu)
SK (1) SK3712001A3 (hu)
WO (1) WO2000017173A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10020667A1 (de) * 2000-04-19 2001-11-22 Schering Ag Neue Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln
AU2001262200A1 (en) * 2000-04-25 2001-11-07 Schering Aktiengesellschaft Benzoxazine derivatives and benzothiazine derivatives having nos-inhibitory and antioxidant properties
UA105182C2 (ru) * 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2509155A1 (de) * 1975-03-03 1976-09-09 Hoechst Ag 1,4-benzoxazinderivate und verfahren zu ihrer herstellung
US4254121A (en) * 1979-08-13 1981-03-03 Ayerst, Mckenna & Harrison Inc. 3-Oxo-5H-pyrimido[2,1-c][1,4 ]benzoxazines
US4254118A (en) * 1979-08-13 1981-03-03 Ayerst, Mckenna & Harrison Inc. 1-Oxo-5H-pyrimido[2,1-c][1,4]benzthiazine-2-carboxylic acid esters
US4547499A (en) * 1984-05-10 1985-10-15 The Upjohn Company 2,4-Dihydro-2(omega-aminoalkyl)-1H-[1,2,4]triazolo[3,4-c]benzoxazin-1-one anti-allergy drug compounds, compositions and use
RU2136661C1 (ru) * 1993-10-21 1999-09-10 Джи Ди Сирл энд Ко. Амидинопроизводные, их применение и фармацевтическая композиция
US5629322A (en) * 1994-11-15 1997-05-13 Merck & Co., Inc. Cyclic amidine analogs as inhibitors of nitric oxide synthase
DE4442116A1 (de) * 1994-11-25 1996-05-30 Cassella Ag 2-Amino-1,3-thiazine als Hemmstoffe der Stickstoffmonoxid-Synthase
DE19530870A1 (de) * 1994-12-14 1996-06-20 Japan Tobacco Inc Thiazin- oder Thiazepinderivate
TW397812B (en) * 1995-02-11 2000-07-11 Astra Ab Bicyclic isothiourea derivatives useful in therapy
CZ287969B6 (cs) * 1995-08-10 2001-03-14 Astra Pharmaceuticals Limited Amidinový derivát, způsob jeho přípravy, farmaceutický prostředek s jeho obsahem a použití
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
EP0906294B1 (en) * 1996-05-29 2003-01-29 Warner-Lambert Company Benzoxazinone dopamine d4 receptor antagonists
ATE336485T1 (de) * 1997-05-02 2006-09-15 Schering Ag Substituierte heterocyclen und deren verwendung in arzneimitteln
DE59810359D1 (de) 1997-09-08 2004-01-15 Schering Ag Benzoxazin- und benzothiazin-derivate und deren verwendung in arzneimitteln

Also Published As

Publication number Publication date
PT1114037E (pt) 2004-09-30
WO2000017173A1 (de) 2000-03-30
CN1319097A (zh) 2001-10-24
ES2221442T3 (es) 2004-12-16
AU6195499A (en) 2000-04-10
DE19844291A1 (de) 2000-03-23
HUP0103505A3 (en) 2003-05-28
CN1144794C (zh) 2004-04-07
SK3712001A3 (en) 2001-09-11
JP2002526481A (ja) 2002-08-20
AR020474A1 (es) 2002-05-15
NO20011339D0 (no) 2001-03-16
DK1114037T3 (da) 2004-08-16
ATE266647T1 (de) 2004-05-15
NO20011339L (no) 2001-05-09
CZ2001988A3 (cs) 2001-08-15
PE20001035A1 (es) 2000-10-18
NZ510562A (en) 2003-08-29
DE59909486D1 (de) 2004-06-17
BR9913856A (pt) 2001-06-12
EP1114037B1 (de) 2004-05-12
US6841550B1 (en) 2005-01-11
EP1114037A1 (de) 2001-07-11
CA2341170A1 (en) 2000-03-30
AU751381B2 (en) 2002-08-15
KR20010075199A (ko) 2001-08-09
PL346699A1 (en) 2002-02-25

Similar Documents

Publication Publication Date Title
HUP0103111A3 (en) Epothilone derivatives, process for their preparation and their use
HUP0100072A3 (en) Phenoxazine, phenthiazine derivatives, their use in medicine; process for their preparation and pharmaceutical compositions containing them
PL345162A1 (en) Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0203425A3 (en) Quinazoline derivatives, process for their preparation and their use
HUP0103404A3 (en) Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
PL351491A1 (en) 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
HUP0002718A3 (en) Piperazine derivatives, process for their preparation and medicaments containing the same
ZA971659B (en) Erythromycin derivatives, their preparation process and their use as medicaments.
HRP20010335B1 (en) Novel erythromycin derivatives, preparation method and use as medicines
HUP9803040A3 (en) Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
ZA997176B (en) Derivatives of erythromycin, their preparation process and their use as medicaments.
AU9633098A (en) Benzoxazine derivatives, preparation and application in therapy
HUP0102056A3 (en) Fused benzoxazine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0104033A3 (en) 1-benzoyl-tetrahydropyridazine derivatives, process for their preparation, their use and medicaments containing the compounds
HUP0204154A3 (en) Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same
HUP0104620A3 (en) 2-phenylpyran-4-one derivatives, process for their preparation and medicaments containing them
HUP0104819A3 (en) Chroman derivatives, their use intermediate and process for their preparation
HUP0101234A3 (en) Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof
HUP0003455A3 (en) Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
HUP0001873A3 (en) Amidino-1,4-benzoxazepine derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0103505A3 (en) Benzoxazine and benzothiazine derivatives, process for their preparation and their use in medicines
HUP0201629A3 (en) Pharmaceutical complex containing eletriptan and cyclodextrin-derivative, pharmaceutical composition containing it, process for its preparation and its use
SI0863139T1 (en) Benzoxazindione derivatives, process for their preparation and their use
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees